Spring 2026
- Big Story: Attacking cancer with isotopes
- Listicle: Five medical radioisotopes – plus a stable isotope – on the rise
- Profile: Ryan Culler: Advancing cancer-fighting isotopes is 'dream job'
- Time Warp: ORNL facilities will supercharge
U.S. isotope production - Spotlight: How actinium-225 attacks a tumor
- Inside ORNL: From production to patients: ORNL is supporting America’s isotope needs
- Feature: Isotopes journey from medical waste to medical treatment
- Sidebar: Tiny tools, sharp aim: Nanobodies target tumors with precision
- Quick Look: ORNL goes all in on targeted alpha therapy